Exogene
ActiveAI for T-cell receptor discovery in oncology.
What it does
Exogene applies deep learning to identify tumor-specific T-cell receptors for cancer therapy development. Researchers leverage these AI-discovered receptors to engineer TCR-based treatments with potential curative efficacy.
Its site says now · captured 2026-08-23
Exogene – Unlocking curative TCR-based therapies
Unlocking curative TCR-based therapies